1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 End User-Based Market Size Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 30)
3.1 Introduction
4 Premium Insights (Page No. – 34)
4.1 Patient Blood Management Market Overview
4.2 Market, By Product
4.3 Market, By End User
4.4 Market, By Component
4.5 Market, By Region
5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Demand for Donated Blood
5.2.1.2 Increasing Number of Blood Donations and Blood Donors
5.2.1.3 Rising Prevalence of Target Diseases
5.2.1.4 Technological Advancements in the Patient Blood Management Industry
5.2.2 Restraints
5.2.2.1 High Cost Associated With Automated Systems
5.2.3 Opportunities
5.2.3.1 Market Penetration Opportunities in Developing Countries
5.2.3.2 Growing Awareness Regarding the Safety of Donated Blood
6 Patient Blood Management Market, By Product (Page No. – 43)
6.1 Introduction
6.2 Instruments
6.2.1 Blood Processing Devices
6.2.1.1 Centrifuges
6.2.1.1.1 Longer Lifespan of Centrifuge Systems to Limit the Growth of This Segment
6.2.1.2 Blood Cell Processors
6.2.1.2.1 Technological Advancements in Centrifugation Systems Might Replace Blood Cell Processors in the Near Future
6.2.2 Blood Transfusion Devices
6.2.2.1 Apheresis Machines
6.2.2.1.1 Favorable Reimbursement for Therapeutic Apheresis Procedures to Support Market Growth
6.2.2.2 Plasma & Plasma Component Separators
6.2.2.2.1 Rising Awareness and Adoption of Hiv Viral Load Testing to Support Market Growth
6.2.2.3 Cell Salvage Systems
6.2.2.3.1 High Cost of Cell Salvage Systems as Well as the Dearth of Trained Professionals to Restrain Market Growth
6.2.2.4 Other Transfusion Devices
6.2.3 Blood Culture Screening Devices
6.2.3.1 Automated Blood Culture Systems
6.2.3.1.1 Automated Blood Culture Systems Segment to Witness Higher Growth During the Forecast Period
6.2.3.2 Supporting Laboratory Equipment
6.2.3.2.1 Growing Automation to Support the Adoption of These Equipment Among End Users
6.2.4 Diagnostic & Testing Instruments
6.2.4.1 PCR Instruments
6.2.4.1.1 Significant Adoption of RT-PCR to Fuel Market Growth
6.2.4.2 Hematology Analyzers
6.2.4.2.1 Product Recalls and Safety Alerts are Expected to Restrain Market Growth
6.2.4.3 NGS Platforms
6.2.4.3.1 Rna-Seq is an Emerging Approach for Cancer Genome Testing
6.2.4.4 Blood Grouping Analyzers
6.2.4.4.1 Increasing Adoption of Blood Grouping Analyzers for Forensic Studies to Support Market Growth
6.2.5 Blood Storage Devices
6.2.5.1 Medical Refrigerators
6.2.5.1.1 Medical Refrigerators Accounted for the Largest Share of the Blood Storage Devices Market in 2018
6.2.5.2 Medical Freezers
6.2.5.2.1 Technological Advancements to Fuel Market Growth
6.3 Accessories
6.3.1 Syringes & Needles
6.3.1.1 Easy Availability and Low Cost of Syringes and Needles Driving Their Adoption
6.3.2 Vials & Tubes
6.3.2.1 Easier Sample Collection Driving the Adoption of Vials and Tubes
6.3.3 Blood Bags
6.3.3.1 Increasing Number of Blood Donations to Support Market Growth
6.3.4 Other Accessories
6.4 Reagents and Kits
6.4.1 Blood Culture Media
6.4.2 Blood Typing Reagents
6.4.3 Slide Staining Reagents
6.4.4 Assay Kits
6.4.5 Other Reagents
6.5 Software
6.5.1 Blood Bank Management Software
6.5.2 Transfusion Management Software
6.5.3 Other Software
7 Patient Blood Management Market, By Component (Page No. – 71)
7.1 Introduction
7.2 Whole Blood & Red Blood Cells
7.2.1 Growing Disease Incidence and Rising Surgical Volumes are Driving Demand for Whole Blood and Erythrocytes
7.3 Plasma
7.3.1 Expanding Applications of Blood Plasma Form a Key Driver of Market Growth
8 Patient Blood Management Market, By End User (Page No. – 74)
8.1 Introduction
8.2 Blood Banks
8.2.1 High Demand for Safe Blood is Driving the Growth of This Segment
8.3 Hospitals
8.3.1 a Large Number of Surgical Procedures Performed in These Facilities is Supporting Market Growth
8.4 Diagnostic Clinics and & Pathology Labs
8.4.1 Stringent Regulatory Compliances for Established Diagnostic Clinics & Pathology Labs is Driving the Demand for Patient Blood Management Products
9 Patient Blood Management Market, By Region (Page No. – 79)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the Market Due to the Presence of Well-Developed Healthcare Infrastructure & Growing Adoption of Advanced Technologies
9.2.2 Canada
9.2.2.1 Increasing Number of Surgical Procedures Performed in the Country to Drive the Market for Patient Blood Management Products
9.3 Europe
9.3.1 Germany
9.3.1.1 Rising Geriatric Population to Fuel the Demand for Blood Transfusion
9.3.2 UK
9.3.2.1 a Large Number of Road Traffic Accidents Will Support the Growth of This Market
9.3.3 France
9.3.3.1 Budgetary Constraints are AGfecting the Sale of Advanced Automated Systems
9.3.4 Spain
9.3.4.1 Government Mandate to Deliver Safe Blood for Transfusion to Drive Market Growth
9.3.5 Italy
9.3.5.1 Increasing Awareness About the Need and Safety of Blood Transfusion Will Drive Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Well-Developed Healthcare System and Favorable Reimbursement Policy in the Country Will Propel Market Growth
9.4.2 China
9.4.2.1 China is Projected to Register Significant Growth Owing to a Large Patient Pool
9.4.3 India
9.4.3.1 Increasing Prevalence of Target Diseases is Driving the Demand for Patient Blood Management Products in the Country
9.4.4 South Korea
9.4.4.1 Government Initiatives to Support Market Growth
9.4.5 Australia
9.4.5.1 Presence of a Highly Developed Healthcare System to Contribute to Market Growth
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Growing Medical Tourism to Support the Growth of the Market in the Region
9.5.2 Mexico
9.5.2.1 Lack of Awareness About Blood Donations is Hampering Market Growth
9.5.3 Rest of Latin America
9.6 Middle East & Africa
10 Competitive Landscape (Page No. – 92)
10.1 Overview
10.2 Market Ranking Analysis, 2018
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, and Collaborations (2017–2019)
10.3.2 Product Launches (2017–2019)
10.3.3 Expansions (2017–2019)
10.3.4 Acquisitions (2017–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Innovators
10.4.4 Dynamic Differentiators
10.4.5 Emerging Companies
11 Company Profiles (Page No. – 97)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Haemonetics Corporation
11.2 Fresenius Se & Co. KGaA
11.3 Terumo Corporation
11.4 Immucor, Inc.
11.5 B. Braun Melsungen AG
11.6 Macopharma
11.7 Biomérieux SA
11.8 Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
11.9 Kaneka Corporation
11.10 Bio-Rad Laboratories, Inc.
11.11 Abbott Laboratories
11.12 Grifols, S.A.
11.13 F. Hoffmann-La Roche LTD.
11.14 Livanova PLC
11.15 Danaher Corporation
11.16 Other Companies
11.16.1 Mediware Information Systems
11.16.2 Kawasumi Laboratories, Inc.
11.16.3 Haier Biomedical
11.16.4 Diatron
11.16.5 Bag Diagnostics GmbH
*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 143)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
